Re-Interpretation of PAM50 Gene Expression as Quantitative Tumor Dimensions Shows Utility for Clinical Trials: Application to Prognosis and Response to Paclitaxel in Breast Cancer
Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-018-05097-5
Full Text
Open PDFAbstract
Available in full text
Date
January 23, 2019
Authors
Publisher
Springer Science and Business Media LLC